RMCM
LLY icon

Reynders McVeigh Capital Management’s Eli Lilly LLY Stock Holding History

Reynders McVeigh Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.51M Sell
5,986
-76
-1% -$77K 0.28% 57
2025
Q4 		$6.51M Sell
6,062
-116
-2% -$111K 0.31% 56
2025
Q3 		$4.71M Sell
6,178
-996
-14% -$741K 0.22% 61
2025
Q2 		$5.59M Sell
7,174
-756
-10% -$587K 0.28% 56
2025
Q1 		$6.55M Sell
7,930
-818
-9% -$681K 0.37% 50
2024
Q4 		$6.75M Sell
8,748
-92
-1% -$76.2K 0.36% 49
2024
Q3 		$7.83M Sell
8,840
-212
-2% -$191K 0.41% 46
2024
Q2 		$8.2M Sell
9,052
-88
-1% -$70.4K 0.47% 45
2024
Q1 		$7.11M Sell
9,140
-1,167
-11% -$831K 0.41% 47
2023
Q4 		$6.01M Sell
10,307
-100
-1% -$58.4K 0.38% 51
2023
Q3 		$5.59M Buy
10,407
+1,213
+13% +$625K 0.38% 47
2023
Q2 		$4.31M Sell
9,194
-22
-0.2% -$9.23K 0.28% 53
2023
Q1 		$3.17M Sell
9,216
-3,510
-28% -$1.18M 0.22% 55
2022
Q4 		$4.66M Hold
12,726
– – 0.34% 50
2022
Q3 		$4.12M Sell
12,726
-29
-0.2% -$9.19K 0.32% 50
2022
Q2 		$4.14M Buy
12,755
+1,018
+9% +$306K 0.31% 52
2022
Q1 		$3.36M Sell
11,737
-42
-0.4% -$10.8K 0.21% 60
2021
Q4 		$3.25M Buy
11,779
+349
+3% +$88.5K 0.18% 61
2021
Q3 		$2.64M Sell
11,430
-480
-4% -$118K 0.16% 69
2021
Q2 		$2.73M Sell
11,910
-59
-0.5% -$11.9K 0.17% 69
2021
Q1 		$2.24M Buy
11,969
+1,653
+16% +$323K 0.15% 75
2020
Q4 		$1.74M Sell
10,316
-1,237
-11% -$185K 0.12% 80
2020
Q3 		$1.71M Buy
11,553
+3,452
+43% +$534K 0.13% 74
2020
Q2 		$1.33M Sell
8,101
-5,145
-39% -$790K 0.12% 84
2020
Q1 		$1.84M Sell
13,246
-510
-4% -$70.1K 0.21% 65
2019
Q4 		$1.81M Buy
13,756
+5,460
+66% +$633K 0.17% 79
2019
Q3 		$928K Buy
8,296
+242
+3% +$26.9K 0.1% 102
2019
Q2 		$892K Hold
8,054
– – 0.1% 103
2019
Q1 		$1.04M Sell
8,054
-135
-2% -$16.4K 0.12% 99
2018
Q4 		$948K Hold
8,189
– – 0.13% 96
2018
Q3 		$879K Sell
8,189
-150
-2% -$15K 0.1% 100
2018
Q2 		$712K Buy
8,339
+1,733
+26% +$142K 0.09% 117
2018
Q1 		$511K Buy
6,606
+152
+2% +$12.2K 0.06% 131
2017
Q4 		$545K Hold
6,454
– – 0.07% 132
2017
Q3 		$552K Hold
6,454
– – 0.07% 129
2017
Q2 		$531K Sell
6,454
-100
-2% -$8.16K 0.07% 136
2017
Q1 		$551K Sell
6,554
-100
-2% -$8.01K 0.08% 135
2016
Q4 		$489K Sell
6,654
-100
-1% -$7.45K 0.07% 143
2016
Q3 		$542K Sell
6,754
-350
-5% -$28K 0.08% 138
2016
Q2 		$559K Hold
7,104
– – 0.08% 136
2016
Q1 		$512K Sell
7,104
-285
-4% -$21.6K 0.08% 139
2015
Q4 		$623K Sell
7,389
-300
-4% -$24.9K 0.1% 109
2015
Q3 		$643K Hold
7,689
– – 0.11% 110
2015
Q2 		$642K Sell
7,689
-100
-1% -$7.62K 0.1% 111
2015
Q1 		$566K Sell
7,789
-471
-6% -$33.5K 0.1% 116
2014
Q4 		$570K Sell
8,260
-250
-3% -$16.9K 0.1% 112
2014
Q3 		$552K Sell
8,510
-84
-1% -$5.32K 0.1% 112
2014
Q2 		$534K Buy
8,594
+1,544
+22% +$92.1K 0.12% 114
2014
Q1 		$415K Buy
7,050
+950
+16% +$53K 0.1% 119
2013
Q4 		$311K Sell
6,100
-4,650
-43% -$233K 0.08% 134
2013
Q3 		$541K Sell
10,750
-145
-1% -$7.59K 0.15% 96
2013
Q2 		$535K Buy
+10,895
New +$593K 0.16% 97

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Reynders McVeigh Capital Management's LLY Position: Q1 2026 in Review

Reynders McVeigh Capital Management reduced its Eli Lilly (LLY) stake by 1.3% in Q1 2026, selling an estimated $77K and leaving 5,986 shares worth $5.51M. The position accounts for 0.28% of the portfolio, ranked #57.

Reynders McVeigh Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.2M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Reynders McVeigh Capital Management held 5,986 shares of Eli Lilly worth $5.51M as of Q1 2026.
  • Reynders McVeigh Capital Management sold 76 Eli Lilly shares in Q1 2026, an estimated $77K.
  • Eli Lilly made up 0.28% of Reynders McVeigh Capital Management's portfolio in Q1 2026, its #57 holding.
  • Reynders McVeigh Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Reynders McVeigh Capital Management's Eli Lilly position peaked at $8.2M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.